Our world leading research featured in the news
UroToday: The TheraP Trial video interview
View this interview with Professor Matthew Cooperberg.
Prostatepedia Magazine: Theranostics issue
Visit the flipbook for this interview with Professor Michael Hofman (pages 8-11).
3-year update from the TheraP trial
Visit this published article in ASCO (American Society of Clinical Oncology) daily news: Lu-177 Vipivotide Tetraxetan Yields Similar OS Versus Cabazitaxel in mCRPC Progressing After Docetaxel
Aussie researchers begin ‘world-first’ clinical trial
Visit this article on the EVOLUTION Phase II clinical trial to evaluate the effectiveness of experimental therapy combined with immunotherapy in patients with prostate cancer.
New technique to diagnose prostate cancer
Visit video and article how prostate cancer experts have revealed they can improve diagnosis through sophisticated imaging techniques instead of invasive biopsies.
Videos
Watch the latest reel from the US Embassy featuring Professor Hofman
Advanced Prostate Cancer Consensus Conference (APCCC)
Dr Renu Eapen presents "Best of Surgical Journals" @ ASCO GU 22
ASCO GU22 | Imaging Biomarkers analysis from the TheraP trial
#EANM21 - Prostate Cancer Along the Yellow Brick Road
Plenary | Role of PSMA PET/CT for de novo vs recurrent disease
TheraP data further support LuPSMA for mCRPC
Professor Michael Hofman talks to Nine News
House of Wellness Program - Channel 7